Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW4AH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,642
Award facts
- Contract value 100% obligated
- $11,641.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,641.64 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on December 29, 2025, with completion expected by December 30, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication commonly used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, supporting military and federal healthcare system needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and federal healthcare systems, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide. The company's established track record of competitively awarded federal contracts demonstrates its capability to meet stringent procurement requirements for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FW4AH?
SPE2DR26FW4AH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FW4AH worth?
The government has obligated $11,642 on SPE2DR26FW4AH.
Is contract SPE2DR26FW4AH an order under another contract?
Yes. SPE2DR26FW4AH is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW4AH competed?
The extent of competition for SPE2DR26FW4AH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award